BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19578211)

  • 1. [Psychological aspects of psychosomatic pathology of large intestine].
    Vashadze ShV
    Georgian Med News; 2009 Jun; (171):37-40. PubMed ID: 19578211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.
    Karling P; Danielsson A; Adolfsson R; Norrback KF
    Neurogastroenterol Motil; 2007 Nov; 19(11):896-904. PubMed ID: 17973640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
    Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
    Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study.
    Brennan BP; Fogarty KV; Roberts JL; Reynolds KA; Pope HG; Hudson JI
    Hum Psychopharmacol; 2009 Jul; 24(5):423-8. PubMed ID: 19548294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower gastrointestinal disorders in patients with irritable bowel syndrome.
    Jurcić D; Bilić A; Schwarz D; Luetic K; Marusić M; Vcev A; Gabrić M; Spoljarić L
    Coll Antropol; 2008 Sep; 32(3):755-9. PubMed ID: 18982748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant psychological morbidity occurs in irritable bowel syndrome: a case-control study using a pharmacy reimbursement database.
    Canavan JB; Bennett K; Feely J; O'Moráin CA; O'Connor HJ
    Aliment Pharmacol Ther; 2009 Feb; 29(4):440-9. PubMed ID: 19035966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome.
    Hyphantis T; Guthrie E; Tomenson B; Creed F
    Pain; 2009 Sep; 145(1-2):196-203. PubMed ID: 19643544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictors of the efficacy of methods for psychocorrection in patients with irritable bowel syndrome and constipation].
    Aĭvazian TA; Zaĭtsev VP; Pakhomova IV; Gusakova EV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (5):6-8. PubMed ID: 19069796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of the anxiety characteristics and depression on clinical aspects and quality of life in patients with irritable bowel syndrome].
    Reséndiz-Figueroa FE; Ortiz-Garrido OM; Pulido D; Arcila-Martínez D; Schmulson M
    Rev Gastroenterol Mex; 2008; 73(1):3-10. PubMed ID: 18792667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between subtypes of irritable bowel syndrome and severity of symptoms associated with panic disorder.
    Sugaya N; Kaiya H; Kumano H; Nomura S
    Scand J Gastroenterol; 2008; 43(6):675-81. PubMed ID: 18569984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychiatric aspects of the irritable bowel syndrome].
    Radziwiłłowicz P; Gil K
    Psychiatr Pol; 2007; 41(1):87-97. PubMed ID: 17494417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity.
    Fitzgerald P; Cassidy Eugene M; Clarke G; Scully P; Barry S; Quigley Eamonn MM; Shanahan F; Cryan J; Dinan Timothy G
    Neurogastroenterol Motil; 2008 Dec; 20(12):1291-7. PubMed ID: 18823288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.
    Dumitraşcu DL; Stănculete M
    Rom J Intern Med; 2006; 44(3):273-80. PubMed ID: 18386606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Depressive and anxiety symptoms, coping strategies in patients with irritable bowel syndrome and inflammatory bowel disease].
    Kovács Z; Kovács F
    Psychiatr Hung; 2007; 22(3):212-21. PubMed ID: 18167418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Humoral factors (beta-endorphin and adrenocorticotropin) in irritable bowel syndrome and their relations with psychological disorders and characteristics of disorders in the large intestine motility].
    Zhukov NA; Sorokina EA; Kazakova AV; Akhmedov VA; Tuleeva NK; Tret'iakova TV; Sen'ko MV
    Eksp Klin Gastroenterol; 2003; (6):46-51, 154. PubMed ID: 15065528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression.
    Friedrich M; Grady SE; Wall GC
    Clin Ther; 2010 Jul; 32(7):1221-33. PubMed ID: 20678672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment for irritable bowel syndrome--psychotropic drugs, antidepressants and so on].
    Sato M; Murakami M
    Nihon Rinsho; 2006 Aug; 64(8):1495-500. PubMed ID: 16898620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of colon ischemia in relation to irritable bowel syndrome.
    Cole JA; Cook SF; Sands BE; Ajene AN; Miller DP; Walker AM
    Am J Gastroenterol; 2004 Mar; 99(3):486-91. PubMed ID: 15056090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.